Clinical trial
Assessment of the Clinical Effectiveness of Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of Non-hospitalized COVID-19 Patients; a Randomized Clinical Trial
NCT04873349 is registered in ClinicalTrials.gov with Shimaa M. Abdelgawad as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of the Clinical Effectiveness of Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of Non-hospitalized COVID-19 Patients; a Randomized Clinical Trial
- Lead sponsor
- Shimaa M. Abdelgawad
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 10, 2021
- Completion date
- August 1, 2022
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19 acute bronchitis, covid-19 respiratory infection, covid19, disseminated intravascular coagulation, symptoms and signs